211 related articles for article (PubMed ID: 4308591)
21. [Influence of drugs used in rheumatology on the blood].
Jaros Z
Vnitr Lek; 1971 Jun; 17(6):610-2. PubMed ID: 5566279
[No Abstract] [Full Text] [Related]
22. [Electrometric demonstration of hypersensitivity to antirheumatic drugs].
Vlcek F
Arch Klin Exp Dermatol; 1970; 237(1):207-9. PubMed ID: 4244588
[No Abstract] [Full Text] [Related]
23. Interactions of anti-rheumatic drugs.
Brooks PM; Bell MA; Mason DI; Buchanan WW
Agents Actions Suppl; 1977; (1):85-95. PubMed ID: 272827
[No Abstract] [Full Text] [Related]
24. [Drug therapy of rheumatic diseases].
Chlud K
Med Welt; 1975 Nov; 26(45):2044-50. PubMed ID: 1105051
[No Abstract] [Full Text] [Related]
25. [Collateral and toxic effects of non-steroid antirheumatic drugs].
Fossati C
Clin Ter; 1979 Aug; 90(3):273-305. PubMed ID: 399874
[No Abstract] [Full Text] [Related]
26. [The Russian roulette of pyrazolones].
Ned Tijdschr Geneeskd; 1983 Jun; 127(26):1166-8. PubMed ID: 6604233
[No Abstract] [Full Text] [Related]
27. [Effect of some antirheumatic agents on the gastric mucous membrane].
Vasilenko VKh; Tsodikov GV; Minushkin ON
Klin Med (Mosk); 1971 Aug; 49(8):3-10. PubMed ID: 4331391
[No Abstract] [Full Text] [Related]
28. [The pharmacotherapy of rheumatoid diseases (2): the action of anti-rheumatic drugs on the synthesis of certain connective tissue components].
Boström H
Lakartidningen; 1969 Oct; 66():Suppl 3:53-5. PubMed ID: 4245944
[No Abstract] [Full Text] [Related]
29. [Antirheumatic drugs. 40].
Mayr E
Pharm Prax; 1969; 10():234-40 contd. PubMed ID: 4908587
[No Abstract] [Full Text] [Related]
30. What drugs for rheumatic diseases?
Waytz PH; Pattee JJ
Geriatrics; 1981 Jul; 36(7):65-79. PubMed ID: 6972334
[No Abstract] [Full Text] [Related]
31. Arthritis and rheumatism: old questions, new answers.
Roth SH
Compr Ther; 1984 Aug; 10(8):58-64. PubMed ID: 6331979
[No Abstract] [Full Text] [Related]
32. Salicylate-induced enzymuria: comparison with other anti-inflammatory agents.
Proctor RA; Kunin CM
Am J Med; 1978 Dec; 65(6):987-93. PubMed ID: 311157
[TBL] [Abstract][Full Text] [Related]
33. Therapy with irritren in rheumatic degenerative diseases.
Georgescu C; Dumitrescu C; Dănău M; Spandonidis S; Costache G
Med Interne; 1986; 24(2):147-51. PubMed ID: 3487823
[TBL] [Abstract][Full Text] [Related]
34. [Pharmacotherapy in rheumatic diseases].
Munthe E
Tidsskr Nor Laegeforen; 1971 Jan; 91(3):219-21. PubMed ID: 5312884
[No Abstract] [Full Text] [Related]
35. [Ocular changes in rheumatic disease].
Guffanti A
Minerva Med; 1978 Sep; 69(46):3134-7. PubMed ID: 309569
[No Abstract] [Full Text] [Related]
36. [Clinical application of fast acting anti-rheumatic and antiphlogistic agents].
Dequeker J; Creytens G; Burssens A
J Belge Rhumatol Med Phys; 1975; 30(1):28-42. PubMed ID: 1083387
[No Abstract] [Full Text] [Related]
37. [Deflazacort is an effective and safe alternative to current corticoids].
Med Clin (Barc); 1991 Mar; 96(8):suppl 1p.. PubMed ID: 2041397
[No Abstract] [Full Text] [Related]
38. [Changes in the gastric mucosa by peroral antirheumatic drugs].
Arsov D; PDavcev P; Vanovski B; Plasevski A; Stavrić G; Guceva
Acta Med Iugosl; 1969; 23(1):86-93. PubMed ID: 5311311
[No Abstract] [Full Text] [Related]
39. The present status of corticotrophin therapy.
Malone DN; Strong JA
Practitioner; 1972 Mar; 208(245):329-37. PubMed ID: 4337178
[No Abstract] [Full Text] [Related]
40. [Incidence of complications in the drug treatment of ankylosing spondylitis].
Svec V; Ondrasík M
Bratisl Lek Listy; 1971 May; 55(5):619-28. PubMed ID: 5582085
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
